Electric Therapy Traction Table Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
The global Biologics and Biosimilars market was valued at US$ 481830 million in 2022 and is projected to reach US$ 843370 million by 2029, at a CAGR of 8.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global key biologics and biosimilars manufacturers include Johnson & Johnson, Pfizer, Roche, Amgen, AbbVie, and others. The top five manufacturers together account for approximately 50% of the market share, with the largest manufacturer being Pfizer with over 20% share. In terms of product categories, monoclonal antibodies are the largest segment with a market share of 43%, followed by vaccines with a 30% share. In terms of applications, hospitals are the top application area, with about 85% of the market share.
Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin, interferon, and monoclonal antibody (mAb) products.
A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product that is almost an identical copy of an original product that manufactured by a different company. Biosimilar are officially approved versions of original "innovator" products and can manufactured when the original product's patent expires. Reference to the innovator product is an integral component of the approval.
This report aims to provide a comprehensive presentation of the global market for Biologics and Biosimilars, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biologics and Biosimilars. This report contains market size and forecasts of Biologics and Biosimilars in global, including the following market information:
Global Biologics and Biosimilars Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Biologics and Biosimilars companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biologics and Biosimilars Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Biologics and Biosimilars Market Segment Percentages, by Type, 2022 (%)
Monoclonal Antibodies
Interferon
Insulin
Vaccines
Others
Global Biologics and Biosimilars Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Biologics and Biosimilars Market Segment Percentages, by Application, 2022 (%)
Hospital
Retail Pharmacy
Other
Global Biologics and Biosimilars Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Biologics and Biosimilars Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biologics and Biosimilars revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Biologics and Biosimilars revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Amgen
AbbVie
Sanofi
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
Biogen
Celltrion
Sobi
3SBIO
Changchun High Tech
Kanghong Pharma
Innovent Biologics
Gan&Lee
Tonghua Dongbao
United Laboratory
Outline of Major Chapters:
Chapter 1: Introduces the definition of Biologics and Biosimilars, market overview.
Chapter 2: Global Biologics and Biosimilars market size in revenue.
Chapter 3: Detailed analysis of Biologics and Biosimilars company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Biologics and Biosimilars in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Biologics and Biosimilars Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biologics and Biosimilars Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biologics and Biosimilars Overall Market Size
2.1 Global Biologics and Biosimilars Market Size: 2022 VS 2029
2.2 Global Biologics and Biosimilars Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Biologics and Biosimilars Players in Global Market
3.2 Top Global Biologics and Biosimilars Companies Ranked by Revenue
3.3 Global Biologics and Biosimilars Revenue by Companies
3.4 Top 3 and Top 5 Biologics and Biosimilars Companies in Global Market, by Revenue in 2022
3.5 Global Companies Biologics and Biosimilars Product Type
3.6 Tier 1, Tier 2 and Tier 3 Biologics and Biosimilars Players in Global Market
3.6.1 List of Global Tier 1 Biologics and Biosimilars Companies
3.6.2 List of Global Tier 2 and Tier 3 Biologics and Biosimilars Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Biologics and Biosimilars Market Size Markets, 2022 & 2029
4.1.2 Monoclonal Antibodies
4.1.3 Interferon
4.1.4 Insulin
4.1.5 Vaccines
4.1.6 Others
4.2 By Type - Global Biologics and Biosimilars Revenue & Forecasts
4.2.1 By Type - Global Biologics and Biosimilars Revenue, 2018-2023
4.2.2 By Type - Global Biologics and Biosimilars Revenue, 2024-2029
4.2.3 By Type - Global Biologics and Biosimilars Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Biologics and Biosimilars Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.1.4 Other
5.2 By Application - Global Biologics and Biosimilars Revenue & Forecasts
5.2.1 By Application - Global Biologics and Biosimilars Revenue, 2018-2023
5.2.2 By Application - Global Biologics and Biosimilars Revenue, 2024-2029
5.2.3 By Application - Global Biologics and Biosimilars Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Biologics and Biosimilars Market Size, 2022 & 2029
6.2 By Region - Global Biologics and Biosimilars Revenue & Forecasts
6.2.1 By Region - Global Biologics and Biosimilars Revenue, 2018-2023
6.2.2 By Region - Global Biologics and Biosimilars Revenue, 2024-2029
6.2.3 By Region - Global Biologics and Biosimilars Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Biologics and Biosimilars Revenue, 2018-2029
6.3.2 US Biologics and Biosimilars Market Size, 2018-2029
6.3.3 Canada Biologics and Biosimilars Market Size, 2018-2029
6.3.4 Mexico Biologics and Biosimilars Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Biologics and Biosimilars Revenue, 2018-2029
6.4.2 Germany Biologics and Biosimilars Market Size, 2018-2029
6.4.3 France Biologics and Biosimilars Market Size, 2018-2029
6.4.4 U.K. Biologics and Biosimilars Market Size, 2018-2029
6.4.5 Italy Biologics and Biosimilars Market Size, 2018-2029
6.4.6 Russia Biologics and Biosimilars Market Size, 2018-2029
6.4.7 Nordic Countries Biologics and Biosimilars Market Size, 2018-2029
6.4.8 Benelux Biologics and Biosimilars Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Biologics and Biosimilars Revenue, 2018-2029
6.5.2 China Biologics and Biosimilars Market Size, 2018-2029
6.5.3 Japan Biologics and Biosimilars Market Size, 2018-2029
6.5.4 South Korea Biologics and Biosimilars Market Size, 2018-2029
6.5.5 Southeast Asia Biologics and Biosimilars Market Size, 2018-2029
6.5.6 India Biologics and Biosimilars Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Biologics and Biosimilars Revenue, 2018-2029
6.6.2 Brazil Biologics and Biosimilars Market Size, 2018-2029
6.6.3 Argentina Biologics and Biosimilars Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Biologics and Biosimilars Revenue, 2018-2029
6.7.2 Turkey Biologics and Biosimilars Market Size, 2018-2029
6.7.3 Israel Biologics and Biosimilars Market Size, 2018-2029
6.7.4 Saudi Arabia Biologics and Biosimilars Market Size, 2018-2029
6.7.5 UAE Biologics and Biosimilars Market Size, 2018-2029
7 Biologics and Biosimilars Companies Profiles
7.1 Roche
7.1.1 Roche Company Summary
7.1.2 Roche Business Overview
7.1.3 Roche Biologics and Biosimilars Major Product Offerings
7.1.4 Roche Biologics and Biosimilars Revenue in Global Market (2018-2023)
7.1.5 Roche Key News & Latest Developments
7.2 Amgen
7.2.1 Amgen Company Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen Biologics and Biosimilars Major Product Offerings
7.2.4 Amgen Biologics and Biosimilars Revenue in Global Market (2018-2023)
7.2.5 Amgen Key News & Latest Developments
7.3 AbbVie
7.3.1 AbbVie Company Summary
7.3.2 AbbVie Business Overview
7.3.3 AbbVie Biologics and Biosimilars Major Product Offerings
7.3.4 AbbVie Biologics and Biosimilars Revenue in Global Market (2018-2023)
7.3.5 AbbVie Key News & Latest Developments
7.4 Sanofi
7.4.1 Sanofi Company Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Biologics and Biosimilars Major Product Offerings
7.4.4 Sanofi Biologics and Biosimilars Revenue in Global Market (2018-2023)
7.4.5 Sanofi Key News & Latest Developments
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Company Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Biologics and Biosimilars Major Product Offerings
7.5.4 Johnson & Johnson Biologics and Biosimilars Revenue in Global Market (2018-2023)
7.5.5 Johnson & Johnson Key News & Latest Developments
7.6 Pfizer
7.6.1 Pfizer Company Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Biologics and Biosimilars Major Product Offerings
7.6.4 Pfizer Biologics and Biosimilars Revenue in Global Market (2018-2023)
7.6.5 Pfizer Key News & Latest Developments
7.7 Novo Nordisk
7.7.1 Novo Nordisk Company Summary
7.7.2 Novo Nordisk Business Overview
7.7.3 Novo Nordisk Biologics and Biosimilars Major Product Offerings
7.7.4 Novo Nordisk Biologics and Biosimilars Revenue in Global Market (2018-2023)
7.7.5 Novo Nordisk Key News & Latest Developments
7.8 Eli Lilly
7.8.1 Eli Lilly Company Summary
7.8.2 Eli Lilly Business Overview
7.8.3 Eli Lilly Biologics and Biosimilars Major Product Offerings
7.8.4 Eli Lilly Biologics and Biosimilars Revenue in Global Market (2018-2023)
7.8.5 Eli Lilly Key News & Latest Developments
7.9 Novartis
7.9.1 Novartis Company Summary
7.9.2 Novartis Business Overview
7.9.3 Novartis Biologics and Biosimilars Major Product Offerings
7.9.4 Novartis Biologics and Biosimilars Revenue in Global Market (2018-2023)
7.9.5 Novartis Key News & Latest Developments
7.10 Merck
7.10.1 Merck Company Summary
7.10.2 Merck Business Overview
7.10.3 Merck Biologics and Biosimilars Major Product Offerings
7.10.4 Merck Biologics and Biosimilars Revenue in Global Market (2018-2023)
7.10.5 Merck Key News & Latest Developments
7.11 Biogen
7.11.1 Biogen Company Summary
7.11.2 Biogen Business Overview
7.11.3 Biogen Biologics and Biosimilars Major Product Offerings
7.11.4 Biogen Biologics and Biosimilars Revenue in Global Market (2018-2023)
7.11.5 Biogen Key News & Latest Developments
7.12 Celltrion
7.12.1 Celltrion Company Summary
7.12.2 Celltrion Business Overview
7.12.3 Celltrion Biologics and Biosimilars Major Product Offerings
7.12.4 Celltrion Biologics and Biosimilars Revenue in Global Market (2018-2023)
7.12.5 Celltrion Key News & Latest Developments
7.13 Sobi
7.13.1 Sobi Company Summary
7.13.2 Sobi Business Overview
7.13.3 Sobi Biologics and Biosimilars Major Product Offerings
7.13.4 Sobi Biologics and Biosimilars Revenue in Global Market (2018-2023)
7.13.5 Sobi Key News & Latest Developments
7.14 3SBIO
7.14.1 3SBIO Company Summary
7.14.2 3SBIO Business Overview
7.14.3 3SBIO Biologics and Biosimilars Major Product Offerings
7.14.4 3SBIO Biologics and Biosimilars Revenue in Global Market (2018-2023)
7.14.5 3SBIO Key News & Latest Developments
7.15 Changchun High Tech
7.15.1 Changchun High Tech Company Summary
7.15.2 Changchun High Tech Business Overview
7.15.3 Changchun High Tech Biologics and Biosimilars Major Product Offerings
7.15.4 Changchun High Tech Biologics and Biosimilars Revenue in Global Market (2018-2023)
7.15.5 Changchun High Tech Key News & Latest Developments
7.16 Kanghong Pharma
7.16.1 Kanghong Pharma Company Summary
7.16.2 Kanghong Pharma Business Overview
7.16.3 Kanghong Pharma Biologics and Biosimilars Major Product Offerings
7.16.4 Kanghong Pharma Biologics and Biosimilars Revenue in Global Market (2018-2023)
7.16.5 Kanghong Pharma Key News & Latest Developments
7.17 Innovent Biologics
7.17.1 Innovent Biologics Company Summary
7.17.2 Innovent Biologics Business Overview
7.17.3 Innovent Biologics Biologics and Biosimilars Major Product Offerings
7.17.4 Innovent Biologics Biologics and Biosimilars Revenue in Global Market (2018-2023)
7.17.5 Innovent Biologics Key News & Latest Developments
7.18 Gan&Lee
7.18.1 Gan&Lee Company Summary
7.18.2 Gan&Lee Business Overview
7.18.3 Gan&Lee Biologics and Biosimilars Major Product Offerings
7.18.4 Gan&Lee Biologics and Biosimilars Revenue in Global Market (2018-2023)
7.18.5 Gan&Lee Key News & Latest Developments
7.19 Tonghua Dongbao
7.19.1 Tonghua Dongbao Company Summary
7.19.2 Tonghua Dongbao Business Overview
7.19.3 Tonghua Dongbao Biologics and Biosimilars Major Product Offerings
7.19.4 Tonghua Dongbao Biologics and Biosimilars Revenue in Global Market (2018-2023)
7.19.5 Tonghua Dongbao Key News & Latest Developments
7.20 United Laboratory
7.20.1 United Laboratory Company Summary
7.20.2 United Laboratory Business Overview
7.20.3 United Laboratory Biologics and Biosimilars Major Product Offerings
7.20.4 United Laboratory Biologics and Biosimilars Revenue in Global Market (2018-2023)
7.20.5 United Laboratory Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LED Light-Up Blanket Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 116 |
Pelvic Floor Functional Magnetic Stimulator Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Multi-Modality Biofeedback System Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
High Frequency Evaluation and Therapy Device Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Choose License Type
Why Choose Us ?
24/7 Research support
Quality assurance
Information security
The report efficiently evaluates the market from various dimensions to deliver an
end-product that is informative, elaborate, and accurate and includes detailed
market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast.
The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of
xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the
industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market
opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE
analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing
initiatives, pricing analysis, competitive landscape which help businesses in
decision making. The analysis data is based on current and historical market trends
which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any
organization to gain insight into specific business sector, aligned with specific area
of interest. Thus, SMI offers more accurate, pragmatic, and actionable information
specifically tailored to suit your business needs.
